Population-based retrospective nested case-control study evaluating effectiveness of GARDASIL™ /GARDASIL™9 against adult-onset recurrent respiratory papillomatosis (AoRRP) in Sweden, Denmark, and Norway (V503-088) First published 05/10/2022 Last updated 29/08/2025 EU PAS number:EUPAS48452 Study Ongoing